Immunomodulatory activities of small host defense peptides

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 1727-1732

  Bowdish, Dawn M E ^a   Davidson, Donald J ^b   Scott, Monisha G ^a,c   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Inimex Pharmaceuticals Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTENECIN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE; CYTOKINE; ENDOTOXIN; INDOLICIDIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROTEIN BAC2A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG POTENTIATION; ESCHERICHIA COLI; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATTLE; CELL LINE; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES;

EID: 18244366046     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.1727-1732.2005     Document Type: Article

References (41)

1. Bowdish, D. M. E., D. J. Davidson, and R. E. W. Hancock. 2005. A reevaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6:35-51.
2. Bowdish, D. M. E., D. J. Davidson, D. P. Speert, and R. E. W. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172:3758-3765.
3. Ciornei, C. D., A. Egesten, M. Engstrom, K. Tornebrandt, and M. Bodelsson. 2002. Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis. Acta Anaesthesiol. Scand. 46:1111-1118.
4. Cozens, A. L., M. J. Yezzi, K. Kunzelmann, T. Ohrui, L. Chin, K. Eng, W. E. Finkbeiner, J. H. Widdicombe, and D. C. Gruenert. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47.
5. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069-1074.
6. Diamond, G., J. P. Russell, and C. L. Bevins. 1996. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93:5156-5160.
7. Falla, T. J., D. N. Karunaratne, and R. E. W. Hancock. 1996. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271:19298-19303.
8. Gennaro, R., L. Dolzani, and D. Romeo. 1983. Potency of bactericidal proteins purified from the large granules of bovine neutrophils. Infect. Immun. 40:684-690.
9. Gennaro, R., M. Zanetti, M. Benincasa, E. Podda, and M. Miani. 2002. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8:763-778.
10. Gough, M., R. E. W. Hancock, and N. M. Kelly. 1996. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:4922-4927.
11. Hancock, R. E. W., and D. Devine. 2004. "Antimicrobial" or "host defence" peptides?, p. 1-4. In D. Devine and R. E. W. Hancock (ed.). Mammalian host defence peptides. Cambridge University Press, New York, N.Y.
12. Hsu, Y. W., K. H. Chi, W. C. Huang, and W. W. Lin. 2001. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J. Immunol. 166:5388-5397.
13. Jiang, J., P. Zhu, Z. Wang, Y. He, D. Liu, K. Tian, and Y. Diao. 1998. Protective effect of bactericidal/permeability-increasing protein in mice with E. coli sepsis. Chin. J. Traumatol. 1:21-24.
14. Kim, S. T., H. E. Cha, D. Y. Kim, G. C. Han, Y. S. Chung, Y. J. Lee, Y. J. Hwang, and H. M. Lee. 2003. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 123:81-85.
15. Krijgsveld, J., S. A. Zaat, J. Meeldijk, P. A. van Veelen, G. Fang, B. Poolman, E. Brandt, J. E. Ehlert, A. J. Kuijpers, G. H. Engbers, J. Feijen, and J. Dankert. 2000. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 275:20374-20381.
16. Lau, Y. E., A. Rozek, M. G. Scott, D. L. Goosney, D. J. Davidson, and R. E. W. Hancock. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 73:583-591.
17. Levin, M., P. A. Quint, B. Goldstein, P. Barton, J. S. Bradley, S. D. Shemie, T. Yeh, S. S. Kim, D. P. Cafaro, P. J. Scannen, B. P. Giroir, et al. 2000. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 356:961-967.
18. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20-26.
19. Niyonsaba, F., A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31:1066-1075.
20. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
21. Resnati, M., I. Pallavicini, J. M. Wang, J. Oppenheim, C. N. Serhan, M. Romano, and F. Blasi. 2002. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA 99:1359-1364.
22. Romeo, D., B. Skerlavaj, M. Bolognesi, and R. Gennaro. 1988. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J. Biol. Chem. 263:9573-9575.
23. Rozek, A., C. L. Friedrich, and R. E. W. Hancock. 2000. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 39:15765-15774.
24. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. W. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883-3891.
25. Scott, M. G., and R. E. W. Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407-431.
26. Scott, M. G., C. M. Rosenberger, M. R. Gold, B. B. Finlay, and R. E. W. Hancock. 2000. An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J. Immunol. 165:3358-3365.
27. Scott, M. G., A. C. Vreugdenhil, W. A. Buurman, R. E. W. Hancock, and M. R. Gold. 2000. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164:549-553.
28. Scott, M. G., H. Yan, and R. E. Hancock. 1999. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect. Immun. 67:2005-2009.
29. Selsted, M. E., M. J. Novotny, W. L. Morris, Y. Q. Tang, W. Smith, and J. S. Cullor. 1992. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 267:4292-4295.
30. Selsted, M. E., Y. Q. Tang, W. L. Morris, P. A. McGuire, M. J. Novotny, W. Smith, A. H. Henschen, and J. S. Cullor. 1993. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J. Biol. Chem. 268:6641-6648.
31. Singh, P. K., H. P. Jia, K. Wiles, J. Hesselberth, L. Liu, B. A. Conway, E. P. Greenberg, E. V. Valore, M. J. Welsh, T. Ganz, B. F. Tack, and P. B. McCray, Jr. 1998. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:14961-14966.
32. Stokes, R. W., and D. Doxsee. 1999. The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell. Immunol. 197:1-9.
33. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
34. Turner, J., Y. Cho, N. N. Dinh, A. J. Waring, and R. I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42:2206-2214.
35. Verbanac, D., M. Zanetti, and D. Romeo. 1993. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett. 317:255-258.
36. Woo, J. S., J. Y. Jeong, Y. J. Hwang, S. W. Chae, S. J. Hwang, and H. M. Lee. 2003. Expression of cathelicidin in human salivary glands. Arch. Otolaryngol. Head Neck Surg. 129:211-214.
37. Wu, M., and R. E. W. Hancock. 1999. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 43:1274-1276.
38. Wu, M., E. Maier, R. Benz, and R. E. W. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
39. Yan, H., and R. E. W. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45:1558-1560.
40. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48.
41. Zhang, G., H. Wu, C. R. Ross, J. E. Minton, and F. Blecha. 2000. Cloning of porcine NRAMP1 and its induction by lipopolysaccharide, tumor necrosis factor alpha, and interleukin-1β: role of CD14 and mitogen-activated protein kinases. Infect. Immun. 68:1086-1093.